
CAVERJECT® - Pfizer
This product information is intended only for residents of the United States.
CAVERJECT® (alprostadil) Instructions For Use Patient information ...
As a trusted authority on our medicines and vaccines' benefits and risks, we empower informed healthcare decisions for their safe and appropriate use.
Caverject (Alprostadil Injection): Side Effects, Uses, Dosage ... - RxList
Oct 14, 2020 · Caverject (Alprostadil Injection) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health …
CaverJect Dosage Guide - Drugs.com
May 13, 2024 · Detailed dosage guidelines and administration information for CaverJect (alprostadil). Includes dose adjustments, warnings and precautions.
Alprostadil (intracavernosal route) - Side effects & dosage
Feb 1, 2025 · Alprostadil injection is used to treat men who have erectile dysfunction (also called sexual impotence). It belongs to a group of medicines called vasodilators that can increase blood flow by …
Caverject: Uses, Taking, Side Effects, Warnings - Medicine.com
Caverject is a prostaglandin E1 agonist used to treat erectile dysfunction (ED) and as an add-on to other medical tests to diagnose ED.
Caverject, Edex (alprostadil intracavernous/urethral) dosing ...
Medscape - Erectile dysfunction dosing for Caverject, Edex (alprostadil intracavernous/urethral), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy &...
CaverJect: Package Insert / Prescribing Information / MOA
May 26, 2024 · CaverJect package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
CAVERJECT® IMPULSE (alprostadil) Instructions For Use - Medical
Before using CAVERJECT, talk to your doctor medication page for healthcare professionals to search for scientific information on Pfizer medications. Also find the prescribing information, …
- [PDF]
Caverject® - Pfizer
Treatment with CAVERJECT should be discontinued in patients who develop penile angulation, cavernosal fibrosis, or Peyronie’s disease. Use of intracavernous alprostadil offers no protection from …